Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoprostenol in Moderate-to-Severe Pulmonary Thrombo-Embolism
NCT01014156Phase 4Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2004
- Primary completion
- Jun 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of epoprostenol in pulmonary embolism (PE), sponsored by Amsterdam University Medical Center. Started Jan 2004; status: completed.
02
Drugs
epoprostenol
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT01014156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01014156.